Published: 2021-12-28

A rare case of jejunal adenocarcinoma with brain metastasis

M. Harish, N. Hariprasad, R. Kannan


Small bowel malignancies are rare entity, with adenocarcinoma being one of common type along with neuroendocrine tumours. Associated with Crohns, celiac disease, FAP and HNPCC. Jejunal adenocarcinoma produce vague symptoms, accounting for late presentation leading to difficult and delayed diagnosis in favour of poor prognosis. Diagnosis is established by CECT abdomen and CEA levels. Ro resection with regional lymphadenectomy and jejunojejunal anastomosis is preferred followed by adjuvant FOLFOX chemotherapy. Here we presenting a 68 years old male, anaemic with vague abdominal pain for 3 months, CECT showed malignant wall thickening involving 10 cm of proximal jejunal loop with no enlarged lymph nodes and CEA was elevated. Proceeded with laparotomy, an irregular hard mass of 10×10 cm involving 20 cm of jejunum with transverse colon infiltration with multiple mesenteric nodes found, composite resection with jejunojejunostomy and colocolic anastomosis done. Histopathology showed poorly differentiated jejunal adenocarcinoma with colonic infiltration with reactive nodes and post operatively on day 7, patient developed seizures and weakness of left upper and lower limbs, MRI brain showed solitary metastasis 2×2 cm in right frontal region and PET CT showed brain metastasis and multiple intraabdominal lymph node, lung and prostate metastasis, planned SBRT for brain metastasis and palliative chemotherapy. Lymph node, liver and peritoneum are common site of metastasis for small bowel adenocarcinoma, very rarely brain metastasis can occur in short time and to be considered if neurological symptoms occur pre and postoperatively.


Brain metastasis, Small bowel, Jejunal adenocarcinoma, Metastatic brain tumor

Full Text:



Townsend C, Beauchamp RD, Evers BM, Mattox K. Sabiston textbook of surgery, first South Asian edition, chapter 49, Elsevier. 2016;1276-2.

Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF. A single-institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg. 2010;199:797-803

Schottenfeld D, Beebe-Dimmer JL, Vigneau FD. The epidemiology and pathogenesis of neoplasia in the small intestine. Ann Epidemiol. 2009;19:58-69.

Apriaco T, zaanan A, Svreck M. Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatment. Dig Lkver Dis. 2014;46:97-104.

Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: Changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249:63-71.

Dabaja BS, Suki D, Pro B, Bonnen M, Ajani J. Adenocarcinoma of the small bowel: Presentation, prognostic factors, and outcome of 217 patients. Cancer. 2004;101:518-26.

Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF. A single-institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg. 2010;199:797-803.

Kayama T, Sato S, Sakurada K, Mizusawa J, Nishikawa R, Narita Y et al. Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504): A phase III, noninferiority, randomized controlled trial. J Clin Oncol. 2018;36:JCO2018786186.

Khrolenko DE, Belaia KA. On metastases to the brain by cancer originating in the small intestine. Zh Nevropatol Psikhiatr Im SS Korsakova. 1967;67.

Salvati M, Cervoni L, Paolini S, Delfini R. Solitary cerebral metastases from intestinal carcinoma. Acta Neurochir (Wien). 1995;133:181-3.